Viewing Study NCT03095612

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:11 PM

Ignite Modification Date: 2025-12-26 @ 11:11 PM

Study NCT ID: NCT03095612

Status: TERMINATED

Last Update Posted: 2024-06-13

First Post: 2017-03-23

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)

Sponsor: University of Texas Southwestern Medical Center

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module